unsere Top Ten

1. Thorsten Lawrenz, Bianca Borchert, MD, Christian Leuner, Markus Bartelsmeier, Jens Reinhardt, Claudia Strunk-Mueller,, Dorothee Meyer Zu Vilsendorf, Marc Schloesser, , Gerald Beer, Frank Lieder, Christoph Stellbrink, Horst Kuhn
   J Am Coll Cardiol, 2011; 57:572-576, doi:10.1016/j.jacc.2010.07.055
   Endocardial Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy Acute Results and 6 Months' Follow-Up in 19 Patients
2. Kuhn H, Lawrenz T, Lieder F, Leuner C, Strunk-Mueller C, Obergassel L, Bartelsmeier M, Stellbrink C. Clin Res Cardiol 2008; 97: 234-243
   Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a ten year experience.
   
3. Kuhn H, Lawrenz T, Lieder F, Leuner C, Strunk-Mueller C, Obergassel L, Bartelsmeier M, Stellbrink C.. Clin Res Cardiol. 2008 Apr;97(4):234-43. Epub 2007 Dec 10.
   Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.
4. Lawrenz T, Obergassel L, Lieder F, Leuner C, Strunk-Müller C, Meyer zu Vilsendorf D, Beer G, Kuhn H, Pacing Clin Electrophysiol. 2005;28(4):295-300.
   Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patientes with hypertrophic obstructive cardiomyopathy
   
5. Kuhn H, Lawrenz T, Lieder F, Gietzen FH, Obergassel L, Strunk-Mueller C, Stolle B, Leuner C. In: Maron BJ (Hrsg) Hypertrophic Cardiomyopathy, Blackwell Futura: 2004; pp. 279-296
   Alcohol septal ablation in the treatment of hypertrophic obstructive cardiomyopathy: A seven year experience.
6. Lawrenz T, Kuhn H. Z Kardiol. 2004;93:493-9.
   Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
7. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED. J Am Coll Cardiol 2003; 42: 1687-713 // Eur Heart J 2003; 24: 1965-1991
   ACC/ESC Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.
8. Maron M S, Olivotto I, Betocchi S, Casey S A, Lesser J R, Losi M A, Cecchi F, Maron,B NEJM 2003;343:295-303
   Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
9. Kuhn H, Gietzen FH, Leuner C, Schafers M, Schober O, Strunk-Muller C, Obergassel L, Freick M, Gockel B, Lieder F, Raute-Kreinsen U. Z Kardiol 2000;89 Suppl 4:IV41-54.
   Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy.
10. Kuhn H, Gietzen F, Leuner C, Gerenkamp T Eur Heart J 1997;18: 846-851
    Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment.